96
Views
102
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the Pro-Oxidant and Antioxidant Actions of L-DOPA and Dopamine in Vitro: Implications for Parkinson's Disease

, , , , , & show all
Pages 95-105 | Received 26 Jun 1995, Published online: 07 Jul 2009
 

Abstract

The antioxidant and pro-oxidant properties of L-DOPA and dopamine were investigated in vitro. Both compounds inhibited the peroxidation of ox-brain phospholipids, with IC50 values of 8.5 μM for dopamine and 450 μM for L-DOPA. Dopamine and L-DOPA reacted with trichloromethyl peroxyl radicals (CC13O2) with rate constants of 2.1 × 107M1s-1 and 1.3 × 107 M-1s-1 respectively. The effects of dopamine and L-DOPA on iron ion- dependent hydroxyl radical generation from H2O2 were c:mplex. In general, low concentrations stimulated OH formation in the presence of ferric-EDTA and, in the case of L-DOPA, ferric-ADP and ferric citrate chelates. Both compounds also reacted with superoxide radical and hypochlor-ous acid. The products of the reaction with HOCI could still inhibit al-antiproteinase and appear to be 'long lived' chloramine-type oxidizing species. Our results suggest that L-DOPA and dopamine might have a complex mixture of pro- and anti- oxidant effects, which could contribute to tissue damage due to oxidative stress in Parkinson's disease and other neurological disorders.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.